Synthesis and evaluation of hybrid sulfonamide‐chalcones with potential antileishmanial activity
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202300440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Nathalia S de Oliveira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Catalise Orgânica, Instituto de Pesquisa de Produtos Naturais, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Chalcones, Chalcone, Antiprotozoal Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Leishmaniasis is an emerging tropical infectious disease caused by a protozoan parasite of the genus Leishmania . In this work, the molecular hybridization between a trimethoxy chalcone and a sulfonamide group was used to generate a series of sulfonamide‐chalcones. A series of eight sulfonamide‐chalcone hybrids were made with good yields (up to 95%). These sulfonamide‐chalcones were tested against promastigotes of Leishmania amazonensis and cytotoxicity against mouse macrophages, which showed good antileishmanial activity with IC 50 = 1.72–3.19 µM. Three of them ( 10c , 10g , and 10h ) were also highly active against intracellular amastigotes and had a good selectivity index (SI > 9). Thus, those three compounds were docked in the cytosolic tryparedoxin peroxidase (cTXNPx) enzyme of the parasite, and molecular dynamics simulations were carried out. This enzyme was selected as a target protein for the sulfonamide‐chalcones due to the fact of the anterior report, which identified a strong and stable interaction between the chalcone NAT22 ( 6 ) and the cTXNPx. In addition, a prediction of the drug‐likeness, and the pharmacokinetic profile of all compounds were made, demonstrating a good profile of those chalcones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Catalise Orgânica, Instituto de Pesquisa de Produtos Naturais, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Laboratório de Modelagem Molecular e Biologia Estrutural Computacional, Instituto de Pesquisas de Produtos Naturais, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Förderung
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
de Oliveira, N. S., de Souza, L. G., de Almeida, V. M., Barreto, A. R. R., Carvalho-Gondim, F., Schaeffer, E., Santos-Filho, O. A., Rossi-Bergmann, B., & da Silva, A. J. M. (2024). Synthesis and evaluation of hybrid sulfonamide‐chalcones with potential antileishmanial activity. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300440
Vancouver
de Oliveira NS, de Souza LG, de Almeida VM, Barreto ARR, Carvalho-Gondim F, Schaeffer E, et al. Synthesis and evaluation of hybrid sulfonamide‐chalcones with potential antileishmanial activity. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300440
BibTeX
@article{deOliveira2024,
author = {de Oliveira, Nathalia S and de Souza, Luana G and de Almeida, Vitor M and Barreto, Arielly R R and Carvalho-Gondim, Felipe and Schaeffer, Edgar and Santos-Filho, Osvaldo A and Rossi-Bergmann, Bartira and da Silva, Alcides J M},
title = {Synthesis and evaluation of hybrid sulfonamide‐chalcones with potential antileishmanial activity},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202300440}
}
EUVIMED